Last reviewed · How we verify
Placebo of Roflumilast
Placebo of Roflumilast is a Small molecule drug developed by FLUIDDA nv. It is currently FDA-approved. Also known as: Placebo.
This is a placebo formulation with no active pharmacological mechanism.
At a glance
| Generic name | Placebo of Roflumilast |
|---|---|
| Also known as | Placebo |
| Sponsor | FLUIDDA nv |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
A placebo of roflumilast contains no active drug substance and produces no direct pharmacological effect. It is used as a control in clinical trials to compare against the active roflumilast formulation (a phosphodiesterase-4 inhibitor). Any observed effects are attributable to the placebo effect rather than drug action.
Approved indications
Common side effects
Key clinical trials
- The Role of Phosphodiesterase Inhibitors in Incretin Secretion (PHASE1)
- Efficacy and Safety of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 70 y) (APTA-2217-05) (PHASE2, PHASE3)
- A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR) (PHASE3)
- A Study to Investigate the Biomarkers of Hemay005 in Adult Participants With Moderate to Severe COPD (PHASE2)
- Evaluation of Efficacy and Safety of Oral Roflumilast for Treatment of Moderate to Severe Atopic Dermatitis in Patients Aged 12 Years and Older: A Pilot Study (PHASE2)
- Evaluating the Neurophysiologic and Clinical Effects of Single Dose Drug Challenge (PHASE2)
- A Pilot Study to Assess How Safe and Effective Oral Roflumilast is for Treating Moderate to Severe Psoriasis in Adults (PHASE2)
- Efficacy and Safety of Roflumilast Cream in Subjects With Atopic Dermatitis (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo of Roflumilast CI brief — competitive landscape report
- Placebo of Roflumilast updates RSS · CI watch RSS
- FLUIDDA nv portfolio CI
Frequently asked questions about Placebo of Roflumilast
What is Placebo of Roflumilast?
How does Placebo of Roflumilast work?
Who makes Placebo of Roflumilast?
Is Placebo of Roflumilast also known as anything else?
What development phase is Placebo of Roflumilast in?
Related
- Manufacturer: FLUIDDA nv — full pipeline
- Also known as: Placebo
- Compare: Placebo of Roflumilast vs similar drugs
- Pricing: Placebo of Roflumilast cost, discount & access